AdvanCell, an Australia-based radiopharmaceutical company, has raised $112m as investor interest in the radiopharma sector ...

The Banks Public Private Partnership, a joint venture of the city of Cincinnati and Hamilton County, has issued a new call ...

Aeon Biopharma Inc’s profitability metrics reveal strong financial health. The company currently boasts a gross margin of -92.52%. The profit margin, also known as the revenue ratio or gross profit ...

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Q1 2025 Management View CEO Emily Leproust highlighted record revenue of $88.7 million for Q1 2025, representing 24% year-over-year growth and 5% sequential growth. The gross margin expanded to 48.3%, ...

Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

Wolfe Research initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating. Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and ...

J&J, AstraZeneca, Novo Nordisk and Roche are among the companies that might take a hit from the soon-to-be-enacted fees, ...

Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

GV Research Platform (GVRP), a leading provider of preclinical research solutions, has announced a strategic partnership with ...